Skip to main content

IDH1-vac

unknown (auto-discovered: peptides-regenerative)

Also known as: IDH1 peptide vaccine

Classification

Biologic

Regulatory Status

investigational; registered trials: NCT07888647 (PHASE2)

Unofficial source

Sources

1

Review

pending review

Overview

Unknown — IDH1-vac was found by open discovery on 2026-10-26 and has not been researched yet.

Evidence and limitations

Known

n/a

Unknown

  • Mechanism, dosing, safety, interactions and efficacy are unknown until research runs on this auto-discovered draft.
Study details: trial conditions, not guidance

These are the conditions researchers used in a controlled trial with medical supervision. They aren't instructions.

Doses found

Doses as found in each source, with its grade. What was found, not a direction.

Studies, trials and professional sources

n/a

Reddit, Facebook, Instagram, forums and blogs

n/a

Claims and grades

  • Not gradedIDH1-vac is being studied in a registered trial: IDH1-vac in Patients With Newly Diagnosed IDH1R132H-positive High-grade Astrocytomas (NCT07888647; PHASE2; NOT_YET_RECRUITING; sponsor German Cancer Research Center; intervention "IDH1-vac" (BIOLOGICAL)).

Sources (1)

Educational reference only — not medical advice.

What people report (anecdote)

CLINICAL DATA (from trials)

Adverse events:

None recorded in our sources.

Effects measured:

Human trials: none found.

ANECDOTE

What people report: anecdote, not evidence

Loading…

Submit a claim you saw
IDH1-vac: what the evidence actually says | BioStack